GeoMx Whole Transcriptome Atlas Grant: UPENN/CHOP
Full Transcriptome Spatial RNA Analysis
The University of Pennsylvania and Children’s Hospital of Philadelphia researchers are invited to apply for a chance to win two slides of GeoMx® Whole Transcriptome Atlas (WTA) probes (mouse, human or canine) and an Illumina flow cell NextSeq 2000 P2 kit.
The GeoMx Human Whole Transcriptome Atlas (GeoMx Hu WTA) provides an unbiased view of 18,000+ protein-coding genes. The GeoMx Hu WTA unlocks new pathways for exploration by researchers and enables RNA profiling in oncology, immunology, neuroscience, developmental biology, and other diverse fields. The GeoMx Hu WTA provides robust and sensitive performance on FFPE or fresh frozen samples.
Mouse models serve a critical role in understanding developmental biology, disease onset, progression, and treatment. Tissue heterogeneity, however, confounds the results from many mouse transcriptome studies based on bulk or single-cell RNA-seq data. Using the GeoMx Mouse Whole Transcriptome Assay, you can apply spatial transcriptomics to reveal the tissue architecture and underlying function in genetically modified mouse models.
Two winners will receive:
- Two slides worth of the WTA probes: mouse, human or canine (WTA probes and seq code pack to run 24+ ROI)
- Project and data analysis consultation
- Commercially available morphology kit
- NanoString reagents needed to run your project
- Illumina flow cell NextSeq 2000 P2 kit
- Grant Deadline: February 10, 2023
- 500-word limit
- Winners will be notified by February 24, 2023
- Projects that include simple and effective region of interest selection strategies with high impact on applicant’s research goals will be chosen as winners.
Apply for the grant by completing this form.
Terms and Conditions
Publication of Project Results:
Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString and each winner: webinar, case study, blog post, or poster presentation. Each winner agrees that NanoString shall have the right to publicly announce the winner’s name and research topic and use anonymized data from the winner’s project in application notes including in marketing materials and seminars.
Eligibility and Requirements:
Applicants must be actively enrolled or employed at an institution or company in a capacity in which they perform life science research and have the ability to ship and analyze samples within 45 days of award notification. The winner must be age 18 or older. Members of the immediate families of NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program. The grant winner will provide 4 slides to be used with the GeoMx® Whole Transcriptome Atlas RNA run through their institutional system or a NanoString selected core lab, CRO or GeoMx DSP accessible site.
By submitting a grant application, each applicant agrees that NanoString may use his or her name, abstract title, and abstract for marketing purposes. All grant applicants agree that NanoString may process the personal data he or she provides as part of application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at nanostring.com/privacy. The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded grant is allowed, except as otherwise permitted by NanoString. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.